Imugene Limited - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Imugene Limited. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Imugene Limited. The Group's principal activities are researching, developing and commercialising animal health technologies. Products include Poultry Productivity Enhancer, Avian Influenza (Bird Flu) Poultry, Coccidiosis, Classical Swine Fever and Porcine Reproductive and Respiratory Syndrome (PRRS) vaccine. Its vaccines are developed from two platform technologies, namely, the fowl adenovirus (FAV) and porcine adenovirus (PAV). Its products improve the health and welfare of animals and reduce or eliminate the use of chemicals and drugs, particularly antibiotics, in production animals. Operations are carried out in Australia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report